Mark Pruzanski
CIK 1559569 · President & CEO · last filed 2026-05-29
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
2
Total Filings
82
Lifetime Open-Market Net
-$51.98M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| EQ | Director | — | $2.81 | — | $0 | 9 | 2026-05-29 |
| INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Director | 718,894 | $19.00 | $13.66M | -$51.98M | 72 | 2021-12-02 |
Recent Filings · Page 4 of 9
82 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-06-13 | EQ | Grant (A) | — | $0 | EDGAR |
| 2019-04-03 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Tax (F) | −1,547 | -$172.5K | EDGAR |
| 2019-01-18 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Grant (A) | +8,500 | $0 | EDGAR |
| 2019-01-03 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Tax (F) | −1,537 | -$154.9K | EDGAR |
| 2018-11-16 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Mixed | — | -$4.62M | EDGAR |
| 2018-10-03 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Tax (F) | −9,759 | -$768.2K | EDGAR |
| 2018-04-09 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Buy (P) | +7,812 | $500.0K | EDGAR |
| 2018-02-22 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-10-04 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Sell (S) | −1,532 | -$90.2K | EDGAR |
| 2017-07-05 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Sell (S) | −1,434 | -$174.6K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.